| Literature DB >> 31904582 |
Diana Y Chen1, David Wolski1, Jasneet Aneja1,2, Lyndon Matsubara1, Brandon Robilotti1, Garrett Hauck1, Paulo Sergio Fonseca de Sousa3, Sonu Subudhi1, Carlos Augusto Fernandes4, Ruben C Hoogeveen1, Arthur Y Kim2, Lia Lewis-Ximenez3, Georg M Lauer1.
Abstract
CD4+ T cell failure is a hallmark of chronic hepatitis C virus (HCV) infection. However, the mechanisms underlying the impairment and loss of virus-specific CD4+ T cells in persisting HCV infection remain unclear. Here we examined HCV-specific CD4+ T cells longitudinally during acute infection with different infection outcomes. We found that HCV-specific CD4+ T cells are characterized by expression of a narrower range of T cell inhibitory receptors compared with CD8+ T cells, with initially high expression levels of PD-1 and CTLA-4 that were associated with negative regulation of proliferation in all patients, irrespective of outcome. In addition, HCV-specific CD4+ T cells were phenotypically similar during early resolving and persistent infection and secreted similar levels of cytokines. However, upon viral control, CD4+ T cells quickly downregulated inhibitory receptors and differentiated into long-lived memory cells. In contrast, persisting viremia continued to drive T cell activation and PD-1 and CTLA-4 expression, and blocked T cell differentiation, until the cells quickly disappeared from the circulation. Our data support an important and physiological role for inhibitory receptor-mediated regulation of CD4+ T cells in early HCV infection, irrespective of outcome, with persistent HCV viremia leading to sustained upregulation of PD-1 and CTLA-4.Entities:
Keywords: Adaptive immunity; Hepatitis; Immunology; Infectious disease; T cells
Mesh:
Substances:
Year: 2020 PMID: 31904582 PMCID: PMC6994113 DOI: 10.1172/JCI126277
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808